Hypomethylation-induced expression of S100A4 in endometrial carcinoma

Modern Pathology

Volumn 20, Issue 10, 2007, Pages 1045-1054

  Xie, Ran ^a   Loose, David S ^b   Shipley, Gregory L ^b   Xie, Susu ^a   Bassett Jr , Roland L ^a   Broaddus, Russell R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Endometrial cancer; Methylation; S100A gene family; S100A4

Indexed keywords

CALVASCULIN; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE; PROGESTERONE RECEPTOR;

ARTICLE; BENIGN TUMOR; CARCINOGENESIS; COMPARATIVE STUDY; CYTOPLASM; DISEASE SEVERITY; DNA METHYLATION; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MIXED TUMOR; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR CELL; TUMOR DIFFERENTIATION; UPREGULATION; UTERUS CARCINOMA;

ADENOCARCINOMA; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; CYSTADENOCARCINOMA, SEROUS; DNA METHYLATION; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MIXED TUMOR, MULLERIAN; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; S100 PROTEINS;

EID: 34548808621     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800940     Document Type: Article

References (47)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-17.
3. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 1995;26:1268-1274.
4. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 2004;444:213-223.
5. Risinger JI, Maxwell GL, Chandramouli GV, et al. Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res 2003;63:6-11.
6. Maxwell GL, Chandramouli GV, Dainty L, et al. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin Cancer Res 2005;11:4056-4066.
7. Deng L, Broaddus RR, McCampbell A, et al. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer. Clin Cancer Res 2005;11:8258-8264.
8. Spoelstra NS, Manning NG, Higashi Y, et al. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res 2006;66:3893-3902.
9. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540-551.
10. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004;322:1111-1122.
11. Gongoll S, Peters G, Mengel M, et al. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 2002;123:1478-1484.
12. Nakamura T, Ajiki T, Murao S, et al. Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol 2002;20:937-941.
13. Sato N, Fukushima N, Maitra A, et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol 2004;164:903-914.
14. Davies BR, O'Donnell M, Durkan GC, et al. Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J Pathol 2002;196:292-299.
15. Cho YG, Nam SW, Kim TY, et al. Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 2003;111:539-545.
16. Albertazzi E, Cajone F, Leone BE, et al. Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression. DNA Cell Biol 1998;17:335-342.
17. Kimura K, Endo Y, Yonemura Y, et al. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 2000;16:1125-1131.
18. Gupta S, Hussain T, MacLennan GT, et al. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J Clin Oncol 2003;21:106-112.
19. Mazzucchelli L. Protein S100A4: too long overlooked by pathologists? Am J Pathol 2002;160:7-13.
20. Li ZH, Bresnick AR. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res 2006;66:5173-5180.
21. FIGO IFoGaO. Announcements. Gynecol Oncol 1989;35:125-127.
22. Callaerts-Vegh Z, Evans KL, Shipley GL, et al. Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery. Br J Pharmacol 2003;138:1505-1516.
23. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826.
24. Sato N, Maitra A, Fukushima N, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003;63:4158-4166.
25. Rosty C, Ueki T, Argani P, et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002;160:45-50.
26. Deng L, Shipley GL, Loose-Mitchell DS, et al. Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium. J Clin Endocrinol Metab 2003;88:2157-2163.
27. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 2004;35:649-662.
28. Tulchinsky E, Ford HL, Kramerov D, et al. Transcriptional analysis of the mts1 gene with specific reference to 50 flanking sequences. Proc Natl Acad Sci USA 1992;89:9146-9150.
29. Engelkamp D, Schafer BW, Mattei MG, et al. Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc Natl Acad Sci USA 1993;90:6547-6551.
30. Yisraeli J, Adelstein RS, Melloul D, et al. Muscle-specific activation of a methylated chimeric actin gene. Cell 1986;46:409-416.
31. Yisraeli J, Frank D, Razin A, et al. Effect of in vitro DNA methylation on beta-globin gene expression. Proc Natl Acad Sci USA 1988;85:4638-4642.
32. Tulchinsky E, Grigorian M, Tkatch T, et al. Transcriptional regulation of the mts1 gene in human lymphoma cells: the role of DNA-methylation. Biochim Biophys Acta 1995;1261:243-248.
33. Nakamura N, Takenaga K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis 1998;16:471-479.
34. Clarke RB, Anderson E, Howell A. Steroid receptors in human breast cancer. Trends Endocrinol Metab 2004;15:316-323.
35. Pedersen KB, Nesland JM, Fodstad O, et al. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies. Br J Cancer 2002;87:1281-1286.
36. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-454.
37. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004;118:277-279.
38. Gotzmann J, Mikula M, Eger A, et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 2004;566:9-20.
39. Okada H, Danoff TM, Kalluri R, et al. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 1997;273:F563-F574.
40. Xue C, Plieth D, Venkov C, et al. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 2003;63:3386-3394.
41. Stein U, Arlt F, Walther W, et al. The metastasis-associated gene S100A4 is a novel target of beta-catenin/ T-cell factor signaling in colon cancer. Gastroenterology 2006;131:1486-1500.
42. Kyo S, Sakaguchi J, Ohno S, et al. High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 2006;37:431-438.
43. Yoshida H, Broaddus R, Cheng W, et al. Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: role in epithelial-mesenchymal transition. Cancer Res 2006;66:889-897.
44. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004;22:4632-4642.
45. Szyf M, Pakneshan P, Rabbani SA. DNA demethylation and cancer: therapeutic implications. Cancer Lett 2004;211:133-143.
46. Swanton C, Nicke B, Downward J. RNA interference, DNA methylation, and gene silencing: a bright future for cancer therapy? Lancet Oncol 2004;5:653-654.
47. Pakneshan P, Szyf M, Farias-Eisner R, et al. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J Biol Chem 2004;279:31735-31744.